<DOC>
	<DOCNO>NCT00125515</DOCNO>
	<brief_summary>The goal study test efficacy memantine ( noncompetitive NMDA receptor antagonist ) adjunct maintenance treatment naltrexone detoxify heroin-dependent individual .</brief_summary>
	<brief_title>Memantine Naltrexone Treatment Opioid Dependence</brief_title>
	<detailed_description>The primary aim study test efficacy memantine , noncompetitive NMDA receptor antagonist , reduce early attrition improve outcome opioid-dependent individual maintain naltrexone . This double-blind , 12-week trial include heroin-dependent patient complete detoxification . Participants randomly assign one three condition : naltrexone placebo , naltrexone memantine ( 15 mg bid ) , naltrexone memantine ( 30 mg bid ) . Naltrexone take 3 time week clinic , memantine placebo take home . In addition , twice week patient receive psychosocial intervention include motivational interview cognitive-behavioral relapse prevention . The goal psychosocial intervention improve compliance medication maintain abstinence . Baseline assessments take compare complete study visit , occur 3 time week .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion : Adult , aged 1860 . Meets DSMIV criterion current opiate dependence disorder least six month duration , support positive urine opiate positive naloxone challenge test diagnosis unclear . Able give inform consent . Exclusion : Pregnancy breastfeed Failure sexually active woman use adequate contraceptive method Active medical illness might make participation hazardous , untreated hypertension , acute hepatitis SGOT SGPT level &gt; 2 time normal , unstable diabetes , chronic organic mental disorder ( e.g. , AIDS dementia ) Active psychiatric disorder might interfere participation make participation hazardous , include DSMIV schizophrenia , bipolar disorder mania psychosis , depressive disorder suicide risk 1 suicide attempt within past year . History allergic reaction buprenorphine , naloxone , memantine , naltrexone , clonidine , clonazepam Currently prescribe regularly take opiate chronic pain medical illness Current participation another intensive psychotherapy substance abuse treatment program currently prescribe psychotropic medication Current participation methadone maintenance treatment program and/or regular use illicit methadone ( &gt; 30 mg per week ) History accidental drug overdose last 3 year significant history overdose follow detoxification , define episode opioidinduced unconsciousness incapacitation , whether medical treatment seek receive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Heroin</keyword>
	<keyword>Opiates</keyword>
	<keyword>naltrexone</keyword>
	<keyword>memantine</keyword>
</DOC>